Jun 08, 2023 / 03:30PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
All right. Good morning, everybody. Thanks for being here. Welcome to the Jefferies 2023 Global Healthcare Conference. I'm Brandon Couillard. I cover life science tools and diagnostics sector here at the firm. Very happy to have Azenta with us back at the conference this year and here to share an update on the story and their progress CFO, Lindon Robertson. Lindon?
Lindon G. Robertson - Azenta, Inc. - Executive VP & CFO
Brandon, thank you very much, and welcome to the Jefferies conference. We are certainly delighted to be here and delighted that you'd spend time with us in this time. I'm going to get right into it. We'll be making some forward-looking statements. We'll be using some non-GAAP measures. So we point out the safe harbor statement. And of course, we point you to the fact that you should be looking at our GAAP metrics as well. And you'll find bridges at the back of our tables presentation to be available on our website later today.
Quickly -- by the way, this is a fresh
Azenta Inc at Jefferies Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot